Clark L. Anderson

The University of Texas Health Science Center at San Antonio — United States

Medicine · Health Sciences

55h-index10.2kcitations131works1.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(82), Glycosylation and Glycoproteins Research(52), Protein purification and stability(15), T-cell and B-cell Immunology(11), Platelet Disorders and Treatments(11)

Publications131 total

The edge visualization metric: Quantifying the improvement of lung SBRT target definition with 4D CBCT
Journal of Applied Clinical Medical Physics·2025· 1 citedOpen Access
Sociodemographic Barriers to Successful Implementation of Optune in Glioblastoma Multiforme Patients
American Journal of Clinical Oncology·2025
52424 A Needs Assessment for Addressing Radiation-induced Dermatologic Side Effects in Breast Cancer Patients
Journal of the American Academy of Dermatology·2024Open Access
Breast Radiation Therapy Survivorship and Cancer Support Groups: an Opportunity for Community Engagement and Education Through the Addressing Breast Cancer Dermatologic Side Effects (ABCDEs) Program
Journal of Cancer Education·2024· 1 cited
Treatment of localized hepatocellular carcinoma: resection vs. ablation vs. radiation
Annals of Palliative Medicine·2024· 4 citedOpen Access
Ablative radiation therapy advances in pancreatic cancer
Digestive Medicine Research·2023Open Access
Characteristics of Inpatient Deaths During the COVID-19 Pandemic at a Comprehensive Cancer Center (Sci214)
Journal of Pain and Symptom Management·2023Open Access
Table S3 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Supplementary Figure S1 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Table S2 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Table S1 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Data from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Table S2 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Table S1 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Data from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Table S3 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Supplementary Figure S1 from Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
2023Open Access
Doubts about the efficacy of tolvaptan for polycystic kidney disease
Clinical Nephrology·2020· 7 cited
Children with appendicitis on the US–Mexico border have socioeconomic challenges and are best served by a freestanding children’s hospital
Pediatric Surgery International·2018· 6 cited
Penetrating trauma in children on the United States-Mexico border: Hispanic ethnicity is not a risk factor
Injury·2018· 1 cited
page 1 of 7Next →

Frequent Co-authors

John M. Robinson(13), R. John Looney(6), Jonghan Kim(6), John T. Brandt(6), Sudhasri Mohanty(5), Anne‐Marie Duchemin(5), Jeanne M. Osborne(5), Chaity Chaudhury(4), William L. Hayton(4), G N Abraham(4), Latha P. Ganesan(4), George Chacko(4), Derry C. Roopenian(3), Daniel D. Sedmak(3), Mark D. Wewers(3), C. L. Bronson(3), Paul M. Guyre(3), Daniel H. Ryan(3), Л. К. Эрнст(3), Susheela Tridandapani(3)